ELISA Kits

Antibodies

Primary Antibodies

PGP9.5

NGAL

IL6

ST2

GFAP

S100A8/A9

D-DIMER

IL17

MYELOPEROXIDASE

SERUM AMYLOID A

MYBPC3

FABP3

REG1 ALPHA

NEUROFILAMENT

IGG4

S100 BETA

B7-1

PD1

B RAF

PON1

PSMA

BETA 2 MICROGLOBULIN

MSMB

PD-L1

S100A1

SERPINB3

Human

SARS-CoV-2

Mouse

Rat

Dog

Human (Does not react with: Mouse)

Monkey

ELISA

WB

FC

IHC

LMNX

IF

IP

Neutralize

Mouse

KO Validated Antibodies

Unconjugated

IgG1

IgG2b

IgG2a

IgG2c

Monoclonal

Indirect

TrueMAB

Druggable Genome

Secreted Protein

Transmembrane

ES Cell Differentiation/IPS

Protease

Transcription Factors

Protein Kinase

Cytokine-cytokine receptor interaction

Hypertrophic cardiomyopathy (HCM)

Parkinson's disease

Graft-versus-host disease

Toll-like receptor signaling pathway

Pathways in cancer

Cytosolic DNA-sensing pathway

Hematopoietic cell lineage

Jak-STAT signaling pathway

NOD-like receptor signaling pathway

Prion diseases

Dilated cardiomyopathy

PPAR signaling pathway

Amyotrophic lateral sclerosis (ALS)

Cell adhesion molecules (CAMs)

Allograft rejection

Autoimmune thyroid disease

Systemic lupus erythematosus

T cell receptor signaling pathway

Type I diabetes mellitus

Viral myocarditis

Acute myeloid leukemia

Bladder cancer

Chemokine signaling pathway

Chronic myeloid leukemia

Colorectal cancer

Endometrial cancer

ErbB signaling pathway

Focal adhesion

Glioma

Insulin signaling pathway

Long-term depression

Long-term potentiation

MAPK signaling pathway

Melanoma

Metabolic pathways

Natural killer cell mediated cytotoxicity

Neurotrophin signaling pathway

Non-small cell lung cancer

Pancreatic cancer

Progesterone-mediated oocyte maturation

Prostate cancer

Regulation of actin cytoskeleton

Renal cell carcinoma

Thyroid cancer

Vascular smooth muscle contraction

mTOR signaling pathway

Antigen processing and presentation

Carrier-free Antibodies

1